Recent Updates
Recently added Catalysts

Fentanyl pectin

Phase 1

Other Acute Pain | Small molecule | Pain |Assertio Holdings, Inc.|Last Updated: May 11, 2017

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

UNCONTROLLED
Total Trials1
Total Enrollment20

FDA Designations

No designations recorded

Clinical trial landscape

Fentanyl pectin · 1 trial · 2 indications

Phase 1 1
NCT01756651Intranasal Fentanyl for Management of Pain Associated With Cystoscopic ProceduresOther Acute Pain
COMPLETED20 Analytics
PHASE1COMPLETED
Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures
Other Acute Pain
NCT0175665120
Unlock trial analytics

Study Design & Arms

AllocationNON_RANDOMIZED
MaskingSINGLE
PurposeSUPPORTIVE_CARE

Interventions

NameTypeDescription
Fentanyl pectinDRUGcomparison of Intranasal fentanyl 100mcg vs 200 mcg.
Unlock Study Design Details

Competitive Landscape -Acute Kidney Injury 11 trials (matched to "Other Acute Pain")

CompanyTickerTrialsLead PhaseDrugs
AstraZeneca PLCAZN1PHASE2AZD4144
Talphera, Inc.TLPH1N/AUndisclosed
SeaStar Medical Holding CorporationICU2 - Undisclosed
Collegium Pharmaceutical, Inc.COLL1 - Flozin
Unlock Competitive Intelligence